Related Experiment Video
Updated: Jun 28, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Crosstalk between IGF1R and estrogen receptor signaling in breast cancer
1Department of Pharmacology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Abstract:
After the discovery that depriving certain breast tumors of estrogen promoted tumor regression, therapeutic strategies aimed at depriving tumors of this hormone were developed. The tumorigenic properties of estrogen are regulated through the estrogen receptor-alpha (ER), making understanding the mechanisms that activate this receptor highly relevant. In addition to estrogen activating the ER, other growth factor pathways, such as the insulin-like growth factors (IGFs), can activate the ER. This review will examine the interaction between these two pathways. Estrogen can activate the growth stimulatory properties of the IGF pathway via ER's genomic and non-genomic functions. Further, blockade of ER function can inhibit IGF-mediated mitogenesis and blocking IGF action can inhibit estrogen stimulation of breast cancer cells. Collectively, these observations suggest that the two growth regulatory pathways are tightly linked and a more thorough understanding of the mechanism of this crosstalk could lead to improved therapeutic strategies in breast cancer.
Insights
Estrogen and insulin-like growth factors (IGFs) pathways crosstalk in breast cancer. Blocking either estrogen receptor (ER) or IGFs inhibits the other
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Estrogen deprivation therapy is a key strategy for treating ER-positive breast tumors.
- Estrogen receptor-alpha (ER) mediates estrogen's tumorigenic properties.
- Growth factor pathways, like insulin-like growth factors (IGFs), can also activate ER.
Purpose of the Study:
- To review the interaction between estrogen and IGF pathways in breast cancer.
- To understand the crosstalk mechanisms between ER and IGF signaling.
- To identify potential therapeutic targets for breast cancer treatment.
Main Methods:
- Literature review of studies examining ER and IGF pathway interactions.
- Analysis of genomic and non-genomic mechanisms of ER activation by estrogen.
- Examination of the effects of blocking ER or IGF signaling on cancer cell growth.
Main Results:
- Estrogen activates IGF pathway's growth-stimulatory properties via ER.
- ER blockade inhibits IGF-mediated mitogenesis.
- IGF blockade inhibits estrogen stimulation of breast cancer cells.
Conclusions:
- The estrogen and IGF pathways are tightly linked in breast cancer.
- Understanding this crosstalk is crucial for developing improved therapeutic strategies.
- Targeting this interaction may offer novel approaches for breast cancer treatment.
Related Concept Videos
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
TGF - β Signaling Pathway
Hedgehog Signaling Pathway

